Jemena Gas has lost its bid for a court to determine a preliminary question in a case by billboard company Manboom that claims the presence of underground gas infrastructure at a site in Mascot, NSW that supplies gas to 1.6 million customers amounts to trespassing.
Tens of thousands of junior doctors who allege they were systemically underpaid have reached a $230 million settlement with NSW Health, the largest settlement ever in an underpayments class action.
Competition law experts have raised doubts about changes to Australia’s merger review regime announced Wednesday, calling the reforms a mixed bag for businesses and the reduced role of the Federal Court “disappointing”.
A judge’s refusal to recuse himself from hearing a costs dispute between MinterEllison and a former client has been overturned, with a court finding that a number of complaints made about the judge by the client created “a contest” between them.
The allowance for genuine redundancies is “not absolute” and employers need to consider measures to redeploy workers, including retraining, an appeals court has said in an unfair dismissal case involving 22 mining workers.
A hearing in a class action to determine the extent of lost sales suffered by cattle exporters following a ban on live exports has been set down for April next year, making the case the oldest unresolved class action on the Federal Court docket.
Hungry Jack’s has resolved a case brought by a franchisee seeking a court injunction blocking the burger chain from launching two restaurants in close proximity to its sites on NSW’s Central Coast.
Victorian Liberal Party leader John Pesutto will face three defamation cases at the same time — one by former Liberal MP Moira Deeming and two by anti-trans activists over last year’s ‘’Let Women Speak’ rally, which was crashed by neo-Nazis.
The state of Victoria has won its bid to prevent lawyers for a class action over Victoria’s COVID-19 hotel quarantine debacle from proofing lay witnesses, ahead of a criminal trial against the Department of Health, which is due to start in May.
The Australian unit of drug giant Mylan has triumphed in a dispute with Australian Taxation Office, with a judge finding the ATO’s assessment for 2020 was “excessive” with respect to interest on loans to fund Mylan’s $1.2 billion acquisition of generic drug maker Alphapharm.